The independent Vaccines and Related Biological Products Advisory Committee will review and discuss data from Pfizer and German startup BioNTech on their vaccine, called BNT162b2. The committee is then expected to vote to recommend the FDA authorize the shot. | |
News Alert Thursday, December 10 |
|
| | | | |
|